CancerCare Manitoba
@cancercaremb.bsky.social
Manitoba's provincially mandated cancer authority providing cancer services throughout Manitoba.
cancercare.mb.ca
cancercare.mb.ca
The TRACTION trial—co-led by CancerCare Manitoba researchers presented yesterday at #ASH2025.
Findings from 8,400 patients show pre-op tranexamic acid reduces blood transfusion with no increase in blood clots, even in cancer patients. A major step towards safer surgeries and sustainable blood supply
Findings from 8,400 patients show pre-op tranexamic acid reduces blood transfusion with no increase in blood clots, even in cancer patients. A major step towards safer surgeries and sustainable blood supply
December 9, 2025 at 4:46 PM
The TRACTION trial—co-led by CancerCare Manitoba researchers presented yesterday at #ASH2025.
Findings from 8,400 patients show pre-op tranexamic acid reduces blood transfusion with no increase in blood clots, even in cancer patients. A major step towards safer surgeries and sustainable blood supply
Findings from 8,400 patients show pre-op tranexamic acid reduces blood transfusion with no increase in blood clots, even in cancer patients. A major step towards safer surgeries and sustainable blood supply
A recent study from our team confirms that isatuximab, a common myeloma treatment— can now be safely delivered in just 30 minutes instead of 75 minutes.
Why it matters: quicker appointments, more comfortable experiences, and more capacity to care for Manitobans.
#patientcare #cancercare
Why it matters: quicker appointments, more comfortable experiences, and more capacity to care for Manitobans.
#patientcare #cancercare
December 3, 2025 at 9:11 PM
A recent study from our team confirms that isatuximab, a common myeloma treatment— can now be safely delivered in just 30 minutes instead of 75 minutes.
Why it matters: quicker appointments, more comfortable experiences, and more capacity to care for Manitobans.
#patientcare #cancercare
Why it matters: quicker appointments, more comfortable experiences, and more capacity to care for Manitobans.
#patientcare #cancercare
Reposted by CancerCare Manitoba
🎓 Exciting news! #PROMISE Madox's Warriors Graduate Studentship officially launches today! Check out the details and help spread the word. #MadoxsWarriors #GradStudentship #CHRIM #CCMB #CancerResearch @um-radyfhs.bsky.social @umbmg.bsky.social @cancercaremb.bsky.social @chrimanitoba.bsky.social
November 28, 2025 at 8:22 PM
🎓 Exciting news! #PROMISE Madox's Warriors Graduate Studentship officially launches today! Check out the details and help spread the word. #MadoxsWarriors #GradStudentship #CHRIM #CCMB #CancerResearch @um-radyfhs.bsky.social @umbmg.bsky.social @cancercaremb.bsky.social @chrimanitoba.bsky.social
Reposted by CancerCare Manitoba
🍁Meet the Team Canada of Cancer Research: A Q&A with Dr. Versha Banerji🍁
After early setbacks, Dr. Banerji found her calling in hematology. Through MOHCCN, she and her team study immune dysfunction in chronic lymphocytic leukemia to develop more targeted cancer therapies.
tinyurl.com/bdf7w8cv
After early setbacks, Dr. Banerji found her calling in hematology. Through MOHCCN, she and her team study immune dysfunction in chronic lymphocytic leukemia to develop more targeted cancer therapies.
tinyurl.com/bdf7w8cv
November 26, 2025 at 4:51 PM
🍁Meet the Team Canada of Cancer Research: A Q&A with Dr. Versha Banerji🍁
After early setbacks, Dr. Banerji found her calling in hematology. Through MOHCCN, she and her team study immune dysfunction in chronic lymphocytic leukemia to develop more targeted cancer therapies.
tinyurl.com/bdf7w8cv
After early setbacks, Dr. Banerji found her calling in hematology. Through MOHCCN, she and her team study immune dysfunction in chronic lymphocytic leukemia to develop more targeted cancer therapies.
tinyurl.com/bdf7w8cv
We are pleased to welcome Dr. Kent Stobart as CancerCare Manitoba’s new President and CEO. A pediatric oncologist and a health care leader, Dr. Stobart brings passion, experience, and a commitment to advancing cancer care and research for all Manitobans. 💙
November 10, 2025 at 7:48 PM
We are pleased to welcome Dr. Kent Stobart as CancerCare Manitoba’s new President and CEO. A pediatric oncologist and a health care leader, Dr. Stobart brings passion, experience, and a commitment to advancing cancer care and research for all Manitobans. 💙